AK
Anupam Kumar
About Anupam Kumar
Data last updated:
Anupam Kumar is a Director at Drug Point Private Limited (since 2022), Director at My Drugpoint Private Limited (since 2022) and Director at Gen X Homes Private Limited (since 2016), and holds 8 more current directorships. The companies operate in Pharma, Real Estate and Construction and Infrastructure and Utilities. The 7 current companies with reported revenue have a combined latest revenue of ₹22.94 Cr; the largest is Drug Point Private Limited at ₹10.64 Cr (FY 2023). Earlier, Anupam Kumar was a Director at Agripulse Bio-Sciences Private Limited (2020–2025) and Director at Gen X Engicon Private Limited (2021–2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Sep 2022 | 2020 | ₹10.64 Cr (FY 2023) | Active | |
| Director | 24 Feb 2022 | 2022 | ₹6.31 Cr (FY 2025) | Active | |
| Director | 01 Jun 2016 | 2016 | ₹2.28 Cr (FY 2023) | Active | |
| Director | 11 Sep 2019 | 2019 | ₹1.95 Cr (FY 2025) | Active | |
| Director | 25 Jun 2020 | 2020 | ₹1.29 Cr (FY 2024) | Active | |
| Director | 28 Jun 2010 | 2010 | ₹34.6 Lakh (FY 2025) | Active | |
| Director | 30 May 2022 | 2022 | ₹10.5 Lakh (FY 2024) | Active | |
| Director | 23 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jul 2020 | 2020 | Active | ||
| Director | 11 Mar 2021 | 2021 | ₹2.1 Lakh (FY 2024) | Active | |
| Director | 02 Nov 2021 | 2021 | Active | ||
| Director | 20 Jan 2017 | 2017 | ₹92.7 Lakh (FY 2022) | Active | |
| Director | 14 Jan 2019 | 2019 | ₹61,000 (FY 2024) | Active | |
| Director | 04 Apr 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anupam Kumar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anupam Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anupam Kumar
Anupam Kumar currently holds 11 directorships: Drug Point Private Limited (Director, since 29 Sep 2022, revenue ₹10.64 Cr (FY 2023)); My Drugpoint Private Limited (Director, since 24 Feb 2022, revenue ₹6.31 Cr (FY 2025)); Gen X Homes Private Limited (Director, since 01 Jun 2016, revenue ₹2.28 Cr (FY 2023)); Genxeco Infra Private Limited (Director, since 11 Sep 2019, revenue ₹1.95 Cr (FY 2025)); Magadh Steel And Cement Private Limited (Director, since 25 Jun 2020, revenue ₹1.29 Cr (FY 2024)); and 6 more.
Anupam Kumar was first appointed on 28 Jun 2010 as Director at Gen X Infra Homes Private Limited. The most recent appointment on record is 23 Apr 2024 at Avir Homes Private Limited.
The 7 current companies of Anupam Kumar that report revenue have a combined latest revenue of ₹22.94 Cr: Drug Point Private Limited ₹10.64 Cr (FY 2023); My Drugpoint Private Limited ₹6.31 Cr (FY 2025); Gen X Homes Private Limited ₹2.28 Cr (FY 2023); Genxeco Infra Private Limited ₹1.95 Cr (FY 2025); Magadh Steel And Cement Private Limited ₹1.29 Cr (FY 2024); and 2 more.
Anupam Kumar held 6 earlier board appointments: Agripulse Bio-Sciences Private Limited (Director, 03 Jul 2020 to 20 Nov 2025); Gen X Engicon Private Limited (Director, 11 Mar 2021 to 15 Oct 2024); Genx Buildcon Private Limited (Director, 02 Nov 2021 to 22 Apr 2024); Rajani Engicon Private Limited (Director, 20 Jan 2017 to 29 Aug 2018); Aasma Engicon Private Limited (Director, 14 Jan 2019 to 17 Mar 2020); and 1 more.
The current boards of Anupam Kumar's companies include Namita Kumari (Drug Point Private Limited), Rakesh Ranjan (Drug Point Private Limited), Srishti Nayyar (Drug Point Private Limited), Kumar Gaurav (Gen X Homes Private Limited), Mohammad Zeyaullah (Gen X Homes Private Limited), Amina Farooq Shaikh (Genxeco Infra Private Limited), among others.